Wilmington Savings Fund Society FSB Buys New Position in Healthpeak Properties, Inc. (NYSE:DOC)

Wilmington Savings Fund Society FSB purchased a new position in Healthpeak Properties, Inc. (NYSE:DOCFree Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 5,484 shares of the real estate investment trust’s stock, valued at approximately $125,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of DOC. State Street Corp purchased a new position in Healthpeak Properties in the third quarter worth $1,093,576,000. Geode Capital Management LLC bought a new stake in Healthpeak Properties during the third quarter worth about $403,898,000. Charles Schwab Investment Management Inc. purchased a new position in shares of Healthpeak Properties in the 3rd quarter worth about $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Healthpeak Properties during the 3rd quarter valued at about $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. purchased a new position in shares of Healthpeak Properties during the 3rd quarter valued at about $102,615,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

DOC opened at $19.76 on Friday. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31. The stock has a market capitalization of $13.82 billion, a PE ratio of 42.04, a price-to-earnings-growth ratio of 2.37 and a beta of 1.13. The stock’s 50 day moving average price is $21.83 and its 200-day moving average price is $21.37. Healthpeak Properties, Inc. has a 52-week low of $16.01 and a 52-week high of $23.26.

Healthpeak Properties (NYSE:DOCGet Free Report) last issued its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The company had revenue of $700.40 million for the quarter, compared to analysts’ expectations of $682.51 million. During the same period in the previous year, the firm posted $0.45 earnings per share. The firm’s revenue for the quarter was up 25.9% compared to the same quarter last year. On average, equities research analysts predict that Healthpeak Properties, Inc. will post 1.8 EPS for the current year.

Healthpeak Properties Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Monday, November 4th were issued a $0.30 dividend. The ex-dividend date was Monday, November 4th. This represents a $1.20 annualized dividend and a yield of 6.07%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 255.32%.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Mizuho reduced their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. Scotiabank increased their target price on shares of Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a report on Monday, September 9th. Evercore ISI boosted their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Monday, September 16th. Robert W. Baird raised their price objective on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Finally, Wells Fargo & Company lowered their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties currently has a consensus rating of “Moderate Buy” and an average price target of $22.93.

Check Out Our Latest Stock Analysis on DOC

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Further Reading

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.